Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone

BACKGROUND AND AIMS: Extended‐release naltrexone (XR‐NTX) is an under‐used treatment option for opioid dependence, today only available in a few countries in the world. Although effective, safe and feasible in short‐term treatment, long‐term data are scarce and there is no recommendation for require...

Descripción completa

Detalles Bibliográficos
Autores principales: Solli, Kristin Klemmetsby, Opheim, Arild, Latif, Zill‐e‐Huma, Krajci, Peter, Benth, Jūratė Šaltytė, Kunoe, Nikolaj, Tanum, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359292/
https://www.ncbi.nlm.nih.gov/pubmed/33338285
http://dx.doi.org/10.1111/add.15378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359292/
https://www.ncbi.nlm.nih.gov/pubmed/33338285
http://dx.doi.org/10.1111/add.15378

Ejemplares similares